Targeted Oncology

, Volume 12, Issue 3, pp 385–385 | Cite as

Erratum to: Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report

  • Andrew J. Dooley
  • Avinash Gupta
  • Mark R. Middleton
Erratum

Erratum to: Targ Oncol (2016) 11:557–563

DOI 10.1007/s11523-015-0410-9

The article Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report, written by Andrew J. Dooley, Avinash Gupta and Mark R. Middleton, was originally published Online First without open access. After publication in volume 11, issue 4, page 557-563 the author decided to opt for Open Choice and to make the article an open access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2016 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Andrew J. Dooley
    • 2
  • Avinash Gupta
    • 1
  • Mark R. Middleton
    • 1
  1. 1.Department of Oncology, NIHR Biomedical Research Centre, Oxford Cancer and Haematology CentreChurchill HospitalOxfordUK
  2. 2.University of Oxford, John Radcliffe HospitalOxfordUK

Personalised recommendations